A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis Meeting Abstract


Authors: Sanchez, L.; Landau, H.; Rosenbaum, C.; Abrahams, A.; Chin, C.; Liotta, B.; Agudo, N.; Ramnath, S.; Hoover, E.; Rahman, H.; Ozbek, U.; Lahoud, O.; Hassoun, H.; Osman, K.
Abstract Title: A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis
Meeting Title: 17th International Myeloma Workshop
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 19
Issue: 10 Suppl.
Meeting Dates: 2019 Sep 12-15
Meeting Location: Boston, MA
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2019-10-01
Start Page: e330
End Page: e331
Language: English
ACCESSION: 139238099
DOI: 10.1016/j.clml.2019.09.543
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:
Notes: Meeting Abstract: SP-217 -- Accession Number: 139238099 -- Entry Date: In Process -- Revision Date: 20191023 -- Publication Type: Article -- Supplement Title: Oct2019 Supplement -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101525386. -- Source: cin20
Altmetric Score
MSK Authors
  1. Hani Hassoun
    159 Hassoun
  2. Heather Jolie Landau
    200 Landau
  3. Elizabeth Hoover
    21 Hoover
  4. Oscar Boutros Lahoud
    13 Lahoud
  5. Hafsa Rahman
    2 Rahman